The emergency use of corona vaccine has been approved for children between the age of two to 18 years. The Subject Expert Committee on COVID-19 has approved Bharat Biotech’s Covaxin for emergency use for children in the age group of 2-18 years. The government will soon issue a guideline regarding this vaccine.
Last week Bharat Biotech completed the Phase II trial of the anti-Covid-19 vaccine Covaxin for use in children below 18 years of age. After which the data was handed over to CDSCO for approval for its emergency use. After which the Drugs Controller General of India has approved the corona vaccine of Covaxin for children in the age group of 2 to 18 years in the country. Children will be given two doses of it.
Bharat Biotech is the only company in India so far that has conducted a trial on a vaccine for children. Its trial was conducted in AIIMS, Delhi. Earlier, Zydus Cadila’s corona vaccine ZyCoV-D has received approval from drug regulator DCGI for ’emergency use’. It will be applied to people above 12 years of age. This is the world’s first DNA-based vaccine.
Must Read – PM Dig At Selective Humans Rights Concern
So far, corona vaccines are being given to people above 18 years of age in the country. Oxford and AstraZeneca’s Covishield and Bharat Biotech’s Covaxin are being given the most in India. Corona vaccination started in the country in January this year. Initially, the vaccine was given to health workers and frontline workers. After this, the sick and the elderly were vaccinated. Now all people above 18 years of age in the country are getting corona vaccines. There is a continuous campaign going on regarding this.
